Article Data

  • Views 533
  • Dowloads 149

Reviews

Open Access

An elderly patient with primary cervical CD5-positive diffuse large B-cell lymphoma: a case report and review of the literature

  • Gengrong Liu1
  • Zhenglei Shen1
  • Liefen Yin1,*,
  • Zhe Zhang2
  • Lingmei Yin2
  • Ke Wang2
  • Huan Yang2
  • Jin Yao2

1Department of Hematology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, P. R. China

2Department of Hematology, Yunnan Tumor Hospital, Kunming, Yunnan, P. R. China

DOI: 10.31083/j.ejgo.2020.04.5298 Vol.41,Issue 4,August 2020 pp.500-503

Submitted: 18 June 2019 Accepted: 08 August 2019

Published: 15 August 2020

*Corresponding Author(s): Liefen Yin E-mail: ylfynkm@126.com

Abstract

Objective: To increase our understanding of the clinical features, diagnosis and treatment, and prognosis of primary cervical CD5+ diffuse large B-cell lymphoma (DLBCL) in an elderly patient. Materials and Methods: We analyzed a case of an elderly patient with primary cervical CD5+ DLBCL and reviewed the literature. Results: The clinical features of this patient were not specific and were manifested as fever, significantly elevated LDH, normal blood test results, an unidentified fraction (6.5%) of cells shown by bone marrow puncture, unexpressed T-system and medullary system markers, and a primary lesion of the cervix found upon positron emission tomography-computed tomography (PET-CT). Cervical biopsy plus immunohistochemical staining showed a CD5+DLBCL, and the diagnosis was confirmed and R-CHOP therapy achieved a favorable therapeutic effect. Conclusions: The clinical manifestations of primary cervical CD5+DLBCL are not specific but PET-CT combined with cervical biopsy can clarify the diagnosis with R-CHOPas the preferred therapeutic regimen.

Keywords

Elderly; Cervical; Diffuse large B cell lymphoma; CD5

Cite and Share

Gengrong Liu,Zhenglei Shen,Liefen Yin,Zhe Zhang,Lingmei Yin,Ke Wang,Huan Yang,Jin Yao. An elderly patient with primary cervical CD5-positive diffuse large B-cell lymphoma: a case report and review of the literature. European Journal of Gynaecological Oncology. 2020. 41(4);500-503.

References

[1] Calli A.O., Rezanko T., Yigit S., Payzin B.: “Lymphoma of the cervix: A diagnostic pitfall on cervicovaginal smear”. J. Cytol., 2012. 29, 213.

[2] Thakral B., Medeiros L.J., Desai P., Lin P., Yin C.C., Tang G., et al.: “Prognostic impact of CD5 expression in diffuse large B­cell lym­ phoma in patients treated with rituximab­EPOCH”. Eur. J. Haema­ tol., 2017, 98, 415.

[3] Semczuk A., Skomra D., Korobowicz E., Balon B., Rechberger T.: “Primary non­Hodgkin’s lymphoma of the uterine cervix mimicking leiomyoma: case report and review of the literature”. Pathol. Res. Pract., 2006, 202, 61.

[4] Korcum A.F., Karadogan I., Aksu G., Aralasmak A., Erdogan G.: “Primary follicular lymphoma of the cervix uteri: a review”. Ann. Hematol., 2007, 86, 623.

[5] Kosari F., Daneshbod Y., Parwaresch R., Krams M., Wacker H.H.: “Lymphomas of the female genital tract: a study of 186 cases and review of the literature”. Am. J. Surg. Pathol., 2005, 29, 1512.

[6] Cubo A.M., Soto Z.M., Cruz M.Á., Doyague M.J., Sancho V., Fraino A., et al.: “Primary diffuse large B cell lymphoma of the uter­ine cervix successfully treated by combined chemotherapy alone: A case report”. Medicine (Baltimore), 2017, 96, e6846.

[7] Pósfai É., Nagy K., Marton I., Bánfalvi A., Kocsis L., Cserni G.: “Incidentally discovered diffuse large B­-cell lymphoma limited to the endocervical mucosa in a young female patient”. Gynecol. Ob­stet. Invest., 2015, 80, 134.

[8] Mandato V.D., Palermo R., Falbo A., Capodanno I., Capodanno F., Gelli M.C., et al.: “Primary diffuse large B­-cell lymphoma of the uterus: case report and review”. Anticancer Res., 2014, 34, 4377.

[9] Kano R., Masaie H., Hino A., Yasuoka H., Nagata S., Ishikawa J., et al.: “Pure intravascular recurrence of CD5­positive diffuse large B-­cell lymphoma primarily arising from the nasal cavities”. Diagn. Pathol., 2018, 13, 46.

[10] Jain P., Fayad L.E., Rosenwald A., Young K.H., O’Brien S.: “Re­cent advances in de novo CD5+ diffuse large B cell lymphoma”. Am. J. Hematol., 2013, 88, 798.

[11] Alinari L., Gru A., Quinion C., Huang Y., Lozanski A., Lozanski G., et al.: “De novo CD5+ diffuse large B­cell lymphoma: Adverse out­comes with and without stem cell transplantation in a large, multi­center, rituximab treated cohort”. Am. J. Hematol., 2016, 91, 395.

[12] Niitsu N., Okamoto M., Tamaru J.I., Yoshino T., Nakamura S., Ohshima K., et al.: “Clinicopathologic characteristics and treatment outcome of the addition of rituximab to chemotherapy for CD5­ positive in comparison with CD5­negative diffuse large B­cell lym­phoma”. Ann. Oncol., 2010, 21, 2069.

[13] Hyo R., Tomita N., Takeuchi K., Aoshima T., Fujita A., Kuwabara H., et al.: “The therapeutic effect of rituximab on CD5­positive and CD5­negative diffuse large B­cell lymphoma”. Hematol. On­col., 2010, 28, 27.

[14] Zhou W., Hua F., Zuo C., Guan Y.: “Primary Uterine Cervical Lym­phoma Manifesting as Menolipsis Staged and Followed Up by FDG PET/CT”. Clin. Nucl. Med., 2016, 41, 590.

[15] Huang H., Li Z., Huang C., Rao J., Xie Q., Cui W., et al.: “CD5 and CD43 Expression are Associate with Poor Prognosis in DLBCL Patients”. Open Med. (Wars.), 2018, 13, 605.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top